Jun 13, 2023 / 03:00PM GMT
Chris Shibutani - Goldman Sachs Group, Inc., Research Division - Research Analyst
Good morning, everybody. Let's start on time. I hate to penalize people who are on time, especially in the morning. So welcome to day 2 of the Goldman Sachs Healthcare Conference. I hope everyone had a very positive and productive first day experience. Jet lag is kind of a bummer, but off we go.
Very pleased to have Pfizer join us this year, and in particular, a year under the belt of Chief Development Officer, William Pao. William, thank you for joining us.
William Pao - Pfizer Inc. - Executive VP & Chief Development Officer
Thanks for having me.
Chris Shibutani - Goldman Sachs Group, Inc., Research Division - Research Analyst
Unfortunately, Dave Denton, the CFO, couldn't be with us here. So we're really going to focus a lot on the pipeline. I know obviously, for Pfizer and for investor communities, there's a lot of big picture questions here, but I think personally that this can be an interesting snapshot to really focus
Pfizer Inc at Goldman Sachs Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers